(Q40433282)

20 September 2017

1 reference

title

T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes (English)

1 reference

20 September 2017

0 references

1 reference

Melief CJ

1

1 reference

PubMed ID

7590825

20 September 2017

Kast WM

series ordinal

2

1 reference

20 September 2017

1 June 1995

1 reference

20 September 2017

Immunological Reviews

1 reference

20 September 2017

145

1 reference

20 September 2017

167-177

1 reference

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00081.X

Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00081.X

In vivo efficacy of virus-derived peptides and virus-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00081.X

Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00081.X

Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00081.X

Potential immunogenicity of oncogene and tumor suppressor gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00081.X

Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00081.X

p53, a potential target for tumor-directed T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00081.X

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/EJI.1830230929

Identifiers

DOI

10.1111/J.1600-065X.1995.TB00081.X

1 reference

20 September 2017

1 reference

PubMed ID

7590825